Biblio

Export 1012 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Keyword is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry., J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
M. Gallucci, Spagnolo, P., Aricò, M., and Grossi, E., Predictors of Response to Cholinesterase Inhibitors Treatment of Alzheimer's Disease: Date Mining from the TREDEM Registry., J Alzheimers Dis, vol. 50, no. 4, pp. 969-79, 2016.
L. D. Gamble, Parker, S., Quinn, C., Bennett, H. Q., Martyr, A., Sabatini, S., Pentecost, C., Collins, R., Dawson, E., Hunt, A., Allan, L., Burns, A., Litherland, R., Victor, C., Matthews, F. E., and Clare, L., A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study., J Alzheimers Dis, vol. 88, no. 2, pp. 679-692, 2022.
L. D. Gamble, Parker, S., Quinn, C., Bennett, H. Q., Martyr, A., Sabatini, S., Pentecost, C., Collins, R., Dawson, E., Hunt, A., Allan, L., Burns, A., Litherland, R., Victor, C., Matthews, F. E., and Clare, L., A Comparison of Well-Being of Carers of People with Dementia and Their Ability to Manage Before and During the COVID-19 Pandemic: Findings from the IDEAL Study., J Alzheimers Dis, vol. 88, no. 2, pp. 679-692, 2022.
L. Gao, Cui, Z., Shen, L., and Ji, H. - F., Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis., J Alzheimers Dis, vol. 50, no. 1, pp. 13-7, 2016.
A. J García-Casal, Goñi-Imizcoz, M., M Perea-Bartolomé, V., Soto-Pérez, F., Smith, S. Jane, Calvo-Simal, S., and Franco-Martín, M., The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer's Disease., J Alzheimers Dis, vol. 57, no. 3, pp. 937-951, 2017.
S. L. Gardener, Rainey-Smith, S. R., and Martins, R. N., Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review., J Alzheimers Dis, vol. 50, no. 2, pp. 301-34, 2016.
S. L. Gardener, Rainey-Smith, S. R., and Martins, R. N., Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review., J Alzheimers Dis, vol. 50, no. 2, pp. 301-34, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells., J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells., J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells., J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
M. Pia Giannoccaro, Bartoletti-Stella, A., Piras, S., Casalena, A., Oppi, F., Ambrosetto, G., Montagna, P., Liguori, R., Parchi, P., and Capellari, S., The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance., J Alzheimers Dis, vol. 62, no. 2, pp. 687-697, 2018.
M. Pia Giannoccaro, Bartoletti-Stella, A., Piras, S., Casalena, A., Oppi, F., Ambrosetto, G., Montagna, P., Liguori, R., Parchi, P., and Capellari, S., The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance., J Alzheimers Dis, vol. 62, no. 2, pp. 687-697, 2018.
R. Gil and Arroyo-Anlló, E. M., Alzheimer's Disease and Face Masks in Times of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
R. Gil and Arroyo-Anlló, E. M., Alzheimer's Disease and Face Masks in Times of COVID-19., J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
J. F. - M. Gilmartin-Thomas, McNeil, J., Powell, A., Malone, D. T., Wolfe, R., Larson, I. C., O'Reilly, C. L., Kirkpatrick, C. M., Kipen, E., Petrovich, T., and J Bell, S., Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study., J Alzheimers Dis, vol. 62, no. 2, pp. 867-876, 2018.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study., J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.

Pages